Akero Therapeutics Cash from Financing (TTM) Insights

Akero Therapeutics Inc (AKRO)

20.90 +0.37 (+1.80%) USD | NASDAQ | Apr 19, 15:44

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	353.32M
September 30, 2023	355.54M
June 30, 2023	572.63M
March 31, 2023	270.65M
December 31, 2022	255.63M
September 30, 2022	253.15M
June 30, 2022	35.32M
March 31, 2022	0.71M
December 31, 2021	0.602M
September 30, 2021	0.418M
June 30, 2021	203.13M

Date	Value
March 31, 2021	202.97M
December 31, 2020	203.11M
September 30, 2020	203.16M
June 30, 2020	-1.228M
March 31, 2020	96.87M
December 31, 2019	95.99M
September 30, 2019	166.10M
June 30, 2019	167.70M
March 31, 2019	84.29M
December 31, 2018	85.01M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-1.228M

Minimum

Jun 2020

572.63M

Maximum

Jun 2023

180.83M

Average

202.97M

Median

Mar 2021

Cash from Financing (TTM) Benchmarks